
================================================================================
JAVELIN.AI - DATA QUALITY EXECUTIVE SUMMARY
Generated: 2026-01-07 20:33:31
================================================================================

OVERVIEW
--------
Total Subjects: 57,997
Total Sites: 3,399
Studies: 23

RISK DISTRIBUTION
-----------------
Subject Level:
  * High Risk: 5,264 subjects (9.1%)
  * Medium Risk: 6,949 subjects (12.0%)
  * Low Risk: 45,784 subjects

Site Level:
  * High Risk Sites: 387 (11.4%)

AI-GENERATED INSIGHT
--------------------
Executive Summary:

Our clinical trial portfolio, comprising 23 studies with a total of 57,997 subjects across 3,399 sites, is currently experiencing several quality control issues that require immediate attention. The risk status indicates 9.1% of subjects are high risk, with 48 critical sites and 5,407 pending serious adverse event (SAE) reviews.

The top issue categories include Max Days Outstanding (29,694 cases), Lab Issues Count (7,427), and SAE Pending Count (5,407). To mitigate these risks effectively, we recommend the following actions for this week:

1. Expedite SAE reviews to minimize delays in subject enrollment and study progression at critical sites.
2. Implement targeted interventions to address lab issues across affected sites, ensuring compliance with standard operating procedures (SOPs) and proper sample handling.
3. Prioritize follow-up on Max Days Outstanding cases to ensure data integrity and accurate reporting, focusing on reducing the outstanding days to meet regulatory requirements.

By addressing these priority areas, we aim to improve data quality across our clinical trial portfolio, ensuring efficient study conduct and compliance with regulatory standards.

CRITICAL ITEMS REQUIRING IMMEDIATE ACTION
-----------------------------------------
[!] PENDING SAE REVIEWS: 5407 subjects have SAE records awaiting review
    Action: Immediate pharmacovigilance review required

[!] CRITICAL SUBJECTS: 4473 subjects require immediate intervention
[!] CRITICAL SITES: 48 sites flagged for urgent quality review

TOP PRIORITIES THIS WEEK
------------------------
1. [CRITICAL] Study_1 - Site 17 (ESP)
   DQI Score: 0.509 | High-risk subjects: 2
   AI Insight: Given the critical risk level (CRITICAL) and low DQI Score of 0.509 for Site 17 in ESP's Study_1, it is imperative to address the identified issues immediately. The top concerns include a high number ...

2. [CRITICAL] Study_16 - Site 759 (TUR)
   DQI Score: 0.388 | High-risk subjects: 1
   AI Insight: Given the CRITICAL risk level and DQI Score of 0.388 for Site 759 in TUR for Study_16, it is recommended to prioritize addressing the following critical issues:

1. SAE Pending Count (2 instances): En...

3. [CRITICAL] Study_1 - Site 27 (CHN)
   DQI Score: 0.340 | High-risk subjects: 2
   AI Insight: Given the critical risk level and low DQI score for Site 27 in CHN for Study_1, it is imperative to address the outstanding data quality issues promptly. The top priorities should focus on resolving p...

4. [CRITICAL] Study_24 - Site 2183 (CHN)
   DQI Score: 0.243 | High-risk subjects: 3
   Action: Schedule urgent site quality call within 48 hours

5. [CRITICAL] Study_11 - Site 417 (ITA)
   DQI Score: 0.233 | High-risk subjects: 1
   Action: Schedule urgent site quality call within 48 hours


RECOMMENDATIONS BY CATEGORY
---------------------------
* Max Days Outstanding: 29694 instances
  Priority: MEDIUM | Action: Escalate data entry delays to site

* Lab Issues Count: 7427 instances
  Priority: MEDIUM | Action: Reconcile lab data with central lab vendor

* Sae Pending Count: 5407 instances
  Priority: CRITICAL | Action: Immediate SAE review and regulatory submission required

* Inactivated Forms Count: 4558 instances
  Priority: LOW | Action: Review inactivated forms for audit trail compliance

* Missing Pages Count: 2569 instances
  Priority: MEDIUM | Action: Issue data query for missing CRF pages

* Missing Visit Count: 867 instances
  Priority: HIGH | Action: Contact site to schedule missed visits or document reason

* Edrr Open Issues: 475 instances
  Priority: LOW | Action: Resolve external data reconciliation discrepancies

* Uncoded Whodd Count: 418 instances
  Priority: LOW | Action: Code medication terms to WHODrug dictionary

* Uncoded Meddra Count: 303 instances
  Priority: HIGH | Action: Code adverse event terms to MedDRA dictionary


================================================================================
